标题/作者	年份
Single-cell epigenomic analyses implicate candidate causal variants at inherited risk loci for Alzheimer’s and Parkinson’s diseases MR Corces, A Shcherbina, S Kundu, MJ Gloudemans, L Frésard, ... Nature genetics 52 (11), 1158-1168	2020
Blood–brain barrier breakdown: an emerging biomarker of cognitive impairment in normal aging and dementia B Hussain, C Fang, J Chang Frontiers in neuroscience 15, 688090	2021
Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models L Sebastian Monasor, SA Müller, AV Colombo, G Tanrioever, J König, ... Elife 9, e54083	2020
The role of innate immunity in Alzheimer's disease HE Ennerfelt, JR Lukens Immunological reviews 297 (1), 225-246	2020
Biological signatures of Alzheimer’s disease P Sharma, A Sharma, F Fayaz, S Wakode, FH Pottoo Current Topics in Medicinal Chemistry 20 (9), 770-781	2020
Nicotinamide, a poly [ADP-ribose] polymerase 1 (PARP-1) inhibitor, as an adjunctive therapy for the treatment of Alzheimer’s disease F Salech, DP Ponce, AC Paula-Lima, CD SanMartin, MI Behrens Frontiers in Aging Neuroscience 12, 255	2020
Current advances in the development of novel polymeric nanoparticles for the treatment of neurodegenerative diseases A Cano, E Sánchez-López, M Ettcheto, A Lopez-Machado, M Espina, ... Nanomedicine 15 (12), 1239-1261	2020
Microbiota in neuroinflammation and synaptic dysfunction: a focus on Alzheimer’s disease D Bairamian, S Sha, N Rolhion, H Sokol, G Dorothée, CA Lemere, ... Molecular neurodegeneration 17 (1), 1-23	2022
Effects of propolis extract and propolis-derived compounds on obesity and diabetes: knowledge from cellular and animal models H Kitamura Molecules 24 (23), 4394	2019
Role of insulin resistance in the Alzheimer's disease progression TT Nguyen, QTH Ta, TTD Nguyen, TT Le, VG Vo Neurochemical research 45, 1481-1491	2020
Multimodal single-cell/nucleus RNA sequencing data analysis uncovers molecular networks between disease-associated microglia and astrocytes with implications for drug repurposing in Alzheimer's disease J Xu, P Zhang, Y Huang, Y Zhou, Y Hou, LM Bekris, J Lathia, CW Chiang, ... Genome research 31 (10), 1900-1912	2021
Acoustofluidic assembly of 3D neurospheroids to model Alzheimer's disease H Cai, Z Ao, L Hu, Y Moon, Z Wu, HC Lu, J Kim, F Guo Analyst 145 (19), 6243-6253	2020
Microglia-targeting nanotherapeutics for neurodegenerative diseases N Zhao, NL Francis, HR Calvelli, PV Moghe APL bioengineering 4 (3)	2020
Nanomedicine-based technologies and novel biomarkers for the diagnosis and treatment of Alzheimer’s disease: From current to future challenges A Cano, P Turowski, M Ettcheto, JT Duskey, G Tosi, E Sánchez-López, ... Journal of nanobiotechnology 19 (1), 122	2021
Glutamate and GABA in microglia-neuron cross-talk in Alzheimer’s disease GA Czapski, JB Strosznajder International Journal of Molecular Sciences 22 (21), 11677	2021
Microvascular alterations in Alzheimer's disease J Steinman, HS Sun, ZP Feng Frontiers in Cellular Neuroscience 14, 618986	2021
Perspectives for new and more efficient multifunctional ligands for Alzheimer′ s disease therapy A Zagórska, A Jaromin Molecules 25 (15), 3337	2020
Neuron‐glia interactions: Molecular basis of alzheimer’s disease and applications of neuroproteomics AM Ibrahim, FH Pottoo, ES Dahiya, FA Khan, JBS Kumar European Journal of Neuroscience 52 (2), 2931-2943	2020
Developing therapies for neurodegenerative disorders: insights from protein aggregation and cellular stress responses GR Mallucci, D Klenerman, DC Rubinsztein Annual Review of Cell and Developmental Biology 36, 165-189	2020
Role of mesenchymal stem cells in counteracting oxidative stress—related neurodegeneration C Angeloni, M Gatti, C Prata, S Hrelia, T Maraldi International journal of molecular sciences 21 (9), 3299	2020

1 - 20

计算机程序会自动估算并确定日期和引用次数。